• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).

作者信息

Miller David T, Lee Kristy, Abul-Husn Noura S, Amendola Laura M, Brothers Kyle, Chung Wendy K, Gollob Michael H, Gordon Adam S, Harrison Steven M, Hershberger Ray E, Klein Teri E, Richards Carolyn Sue, Stewart Douglas R, Martin Christa Lese

机构信息

Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA.

Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.

出版信息

Genet Med. 2022 Jul;24(7):1407-1414. doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.

DOI:10.1016/j.gim.2022.04.006
PMID:35802134
Abstract
摘要

相似文献

1
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.1清单：一项政策声明
Genet Med. 2022 Jul;24(7):1407-1414. doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.
2
ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).ACMG SF v3.2 临床外显子组和基因组测序中报告次要发现的列表：美国医学遗传学与基因组学学会 (ACMG) 的政策声明。
Genet Med. 2023 Aug;25(8):100866. doi: 10.1016/j.gim.2023.100866. Epub 2023 Jun 22.
3
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.0清单：一项政策声明
Genet Med. 2021 Aug;23(8):1381-1390. doi: 10.1038/s41436-021-01172-3. Epub 2021 May 20.
4
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).临床外显子组和基因组测序中次要发现报告的建议，2021年更新：美国医学遗传学与基因组学学会（ACMG）政策声明
Genet Med. 2021 Aug;23(8):1391-1398. doi: 10.1038/s41436-021-01171-4. Epub 2021 May 20.
5
Correspondence on "ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)" by Miller et al.米勒等人就“美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.0清单：政策声明”的通信
Genet Med. 2022 Mar;24(3):744-746. doi: 10.1016/j.gim.2021.10.020. Epub 2021 Nov 30.
6
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.临床外显子组和基因组测序中次要发现报告的建议，2016年更新版（美国医学遗传学与基因组学学会次要发现v2.0）：美国医学遗传学与基因组学学会政策声明
Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17.
7
The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会（ACMG）关于将ACMG次要发现建议用于普通人群筛查的政策声明。
Genet Med. 2019 Jul;21(7):1467-1468. doi: 10.1038/s41436-019-0502-5. Epub 2019 Apr 25.
8
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.ACMG 临床外显子组和基因组测序中偶然发现报告的推荐标准。
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
9
Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).对《美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.0列表：政策声明》的勘误
Genet Med. 2021 Aug;23(8):1582-1584. doi: 10.1038/s41436-021-01278-8.
10
Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.从基因组和外显子组测序数据中发现的具有医学意义的偶然发现的频率和处理方法：系统评价。
Physiol Genomics. 2021 Sep 1;53(9):373-384. doi: 10.1152/physiolgenomics.00025.2021. Epub 2021 Jul 12.

引用本文的文献

1
Assessing the impact of exome sequencing on diagnostic yield in a large cohort of Brazilian patients.评估外显子组测序对一大群巴西患者诊断率的影响。
Rev Assoc Med Bras (1992). 2025 Aug 15;71(7):e20250086. doi: 10.1590/1806-9282.20250086. eCollection 2025.
2
Identification of candidate cardiomyopathy modifier genes through genome sequencing and RNA profiling.通过基因组测序和RNA分析鉴定候选心肌病修饰基因。
Front Cardiovasc Med. 2025 Jul 28;12:1546493. doi: 10.3389/fcvm.2025.1546493. eCollection 2025.
3
Detecting likely germline variants during tumor-based molecular profiling.
在基于肿瘤的分子谱分析过程中检测可能的种系变异。
J Clin Invest. 2025 Aug 1;135(15). doi: 10.1172/JCI190264.
4
Secondary Findings from Exome Sequencing of a Greek Cohort.希腊队列外显子组测序的次要发现
Curr Issues Mol Biol. 2025 Apr 11;47(4):272. doi: 10.3390/cimb47040272.
5
Certain vs. uncertain actionable secondary findings in a cohort of 500 Lebanese participants: What to report to the patient?500名黎巴嫩参与者队列中确定性与不确定性可采取行动的次要发现：该向患者报告什么？
PLoS One. 2025 Jul 18;20(7):e0327471. doi: 10.1371/journal.pone.0327471. eCollection 2025.
6
Returning of individual genetic findings to biobank participants: a mixed methods study results in Lithuania.向生物样本库参与者反馈个体基因研究结果：立陶宛一项混合方法研究的结果
BMC Med Ethics. 2025 Jul 4;26(1):86. doi: 10.1186/s12910-025-01250-0.
7
ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.3列表：一项政策声明
Genet Med. 2025 Aug;27(8):101454. doi: 10.1016/j.gim.2025.101454. Epub 2025 Jun 23.
8
Using large-scale population-based data to improve disease risk assessment of clinical variants.利用基于大规模人群的数据改进临床变异的疾病风险评估。
Nat Genet. 2025 Jun 23. doi: 10.1038/s41588-025-02212-3.
9
Genome Sequencing Uncovers Additional Findings in Phelan-McDermid Syndrome.基因组测序揭示了费兰-麦克德米德综合征的更多发现。
Am J Med Genet B Neuropsychiatr Genet. 2025 Jun 16:e33036. doi: 10.1002/ajmg.b.33036.
10
Monitoring the rate and variability of somatic genomic alterations using long-read sequencing.使用长读长测序监测体细胞基因组改变的速率和变异性。
Sci Rep. 2025 Jun 11;15(1):18397. doi: 10.1038/s41598-025-01690-z.